Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)

Saleema Purayil ¹

Sherin Thalappil ¹

Maryam Al-Nesf ¹

Emek Kocaturk ²

Allergy & Immunology Division Department of Medicine, Hamad Medical Corporation, Doha E-mail: SPurayil3@hamad.qa |

Department of Dermatology, Koc University, Istanbul, Turkey |

Publication type: Journal Article

Publication date: 2022-06-20

Hamad Medical Corporation

Journal: Qatar Medical Journal

scimago Q3

SJR: 0.295

CiteScore: 1.8

Impact factor: —

ISSN: 02538253, 22270426

DOI: 10.5339/qmj.2022.fqac.2

Copy DOI

General Medicine

Found

	1 2
Vaccines	Vaccines, 2, 40% Vaccines 2 publications, 40%
Journal of Allergy and Clinical Immunology: In Practice	Journal of Allergy and Clinical Immunology: In Practice, 1, 20% Journal of Allergy and Clinical Immunology: In Practice 1 publication, 20%
Journal of Allergy and Clinical Immunology Global	Journal of Allergy and Clinical Immunology Global, 1, 20% Journal of Allergy and Clinical Immunology Global 1 publication, 20%
Immunology and Allergy Clinics of North America	Immunology and Allergy Clinics of North America, 1, 20% Immunology and Allergy Clinics of North America 1 publication, 20%
	1 2

	1 2 3
Elsevier	Elsevier, 3, 60% Elsevier 3 publications, 60%
MDPI	MDPI, 2, 40% MDPI 2 publications, 40%
	1 2 3

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex

Found error?

Publisher

Hamad Medical Corporation

Journal

scimago Q3

SJR

0.295

CiteScore

1.8

Impact factor

—

ISSN

02538253

22270426 (Print, Electronic)